SEC Form 4

FORM 4		UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940	OMB APPROVAL OMB Number: 3235-0287 Estimated average burden hours per response: 0.5
	Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person* SCHULER JACK W (Last) (First) (Middle) 100 N. FIELD DRIVE, SUITE 360 (Street) LAKE FOREST IL 60045 (City) (State) (Zip)	2. Issuer Name and Ticker or Trading Symbol SOLENO THERAPEUTICS INC [ SLNO ]	5. Relationship of Reporting Person(s) to Issuer (Check all applicable) Director X 10% Owner Officer (give title below) Other (specify below)
	3. Date of Earliest Transaction (Month/Day/Year) 03/21/2019
	4. If Amendment, Date of Original Filed (Month/Day/Year)	6. Individual or Joint/Group Filing (Check Applicable Line) X Form filed by One Reporting Person Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/21/2019		P		111,407	A	$2.3183	111,407	I	See Footnote(1)
Common Stock	03/22/2019		P		147,645	A	$2.3716	259,052	I	See Footnote(1)
Common Stock	03/25/2019		P		30,014	A	$2.3105	289,066	I	See Footnote(1)
Common Stock	03/26/2019		P		42,745	A	$2.2322	331,811	I	See Footnote(1)
Common Stock	03/27/2019		P		100,000	A	$2.0458	431,811	I	See Footnote(1)
Common Stock	03/28/2019		P		8,970	A	$2.111	440,781	I	See Footnote(1)
Common Stock	03/29/2019		P		11,243	A	$2.0895	452,024	I	See Footnote(1)
Common Stock	04/01/2019		P		146,230	A	$1.9576	598,254	I	See Footnote(1)
Common Stock	04/02/2019		P		5,000	A	$1.9497	603,254	I	See Footnote(1)
Common Stock	04/03/2019		P		10,000	A	$2.0871	613,254	I	See Footnote(1)
Common Stock	04/04/2019		P		30,000	A	$2.1399	643,254	I	See Footnote(1)
Common Stock	04/05/2019		P		47,293	A	$2.0516	690,547	I	See Footnote(1)
Common Stock	04/08/2019		P		2,100	A	$2.0295	692,647	I	See Footnote(1)
Common Stock	04/12/2019		P		6,000	A	$2.0827	698,647	I	See Footnote(1)
Common Stock	04/15/2019		P		21,953	A	$1.9895	720,600	I	See Footnote(1)
Common Stock	04/16/2019		P		10,562	A	$1.9865	731,162	I	See Footnote(1)
Common Stock	04/17/2019		P		20,769	A	$1.9417	751,931	I	See Footnote(1)
Common Stock	04/18/2019		P		4,548	A	$1.9597	756,479	I	See Footnote(1)
Common Stock	04/22/2019		P		10,818	A	$1.989	767,297	I	See Footnote(1)
Common Stock	04/23/2019		P		5,000	A	$2.0259	772,297	I	See Footnote(1)
Common Stock	04/25/2019		P		1,200	A	$1.99	773,497	I	See Footnote(1)
Common Stock	04/26/2019		P		8,448	A	$1.9684	781,945	I	See Footnote(1)
Common Stock	05/01/2019		P		200	A	$1.96	782,145	I	See Footnote(1)
Common Stock	05/02/2019		P		800	A	$1.9763	782,945	I	See Footnote(1)
Common Stock	05/07/2019		P		200	A	$1.99	783,145	I	See Footnote(1)
Common Stock	05/09/2019		P		7,300	A	$2	790,445	I	See Footnote(1)
Common Stock	05/10/2019		P		800	A	$2	791,245	I	See Footnote(1)
Common Stock	05/13/2019		P		10,572	A	$1.9855	801,817	I	See Footnote(1)
Common Stock	05/20/2019		P		33,900	A	$1.9285	835,717	I	See Footnote(1)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The shares are held by the Schuler Family Foundation, for which the Reporting Person serves as President.

Remarks:

The price set forth in column 4 of each line item represents a weighted average purchase price. The number of shares set forth in column 5 of each line item reflects the number of shares beneficially owned as of the date of the transaction following the respective stock purchase.

	/s/ Jack W. Schuler	06/26/2020
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.